Augustine Therapeutics (SA)
Active
VAT
BE 0722.705.230
Address
Gaston Geenslaan 3
3001
Leuven
Established
12-03-2019
Principal activity
Research and experimental development on biotechnology
Crisis resilience of Augustine Therapeutics
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of Augustine Therapeutics
2023
|
2022
|
2021
|
2020
|
||||
|---|---|---|---|---|---|---|---|
| Profit/Loss | -€4,160,747 | -33% |
-€3,129,266 | -76% |
-€1,779,592 | 42% |
-€3,047,004 |
| Equity | -€2,187,454 | -211% |
€1,973,293 | 265% |
€541,037 | -69% |
€1,720,629 |
| Gross margin | -€515,794 | 74% |
-€1,985,373 | -35% |
-€1,466,187 | 48% |
-€2,836,670 |
| Employees | 3,2 FTE | 45% |
2,2 FTE | 214% |
0,7 FTE | - |
- |
Publications in the Belgian Official Journal for Augustine Therapeutics
Frequently asked questions
What is the VAT number of Augustine Therapeutics?
The VAT number of Augustine Therapeutics is BE0722705230.
When was Augustine Therapeutics founded?
Augustine Therapeutics was founded on 12-03-2019.
What is the address of Augustine Therapeutics?
The current registered office of Augustine Therapeutics is located at Gaston Geenslaan 3, 3001 Leuven.
When was the last time Augustine Therapeutics filed their annual financial statements?
The most recent financial statements of Augustine Therapeutics were filed on 28-06-2024. You can view them here.
How many employees does Augustine Therapeutics have?
There are 3,2 FTEs working at Augustine Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Augustine Therapeutics?
At the time of its most recent financial statements, Augustine Therapeutics did not publish any turnover figures. Augustine Therapeutics reported a gross margin of -€515,793.94.
